...
首页> 外文期刊>Journal of biomaterials science >Tumor targeting HPMA-porphyrin-Tc-99m copolymer molecular imaging agent
【24h】

Tumor targeting HPMA-porphyrin-Tc-99m copolymer molecular imaging agent

机译:肿瘤靶向HPMA-卟啉-Tc-99m共聚物分子显像剂

获取原文
获取原文并翻译 | 示例
           

摘要

Porphyrins typically show preferential uptake and retention by tumor tissues via receptor-mediated endocytosis of low-density lipoproteins. To investigate the relative importance of active and passive targeting strategies, the synthesis, characterization, in vitro uptake, and in vivo biodistribution of specific targeting porphyrin HPMA [HPMA: N-(2-hydroxypropyl)methacrylamide] copolymer tracer poly(HPMA)-porphyrin-DTPA-Tc-99m (DTPA: diethylenetriaminepentaacetic acid), nonspecific targeting HPMA copolymer tracer poly(HPMA)-DTPA-Tc-99m, and nontargeting tracer DTPA-Tc-99m are described in this study. The results showed that the cellular accumulation of poly(HPMA)-porphyrin-DTPA-Tc-99m complex was found to be time-dependent. The uptake of poly(HPMA)-porphyrin-DTPA-Tc-99m was significantly higher than that of poly(HPMA)-DTPA-Tc-99m, indicating that uptake of the poly(HPMA)-porphyrin-DTPA-Tc-99m was active binding. The uptake of poly(HPMA)-DTPA-Tc-99m was significantly higher than that of DTPA-Tc-99m, suggesting that uptake of the poly(HPMA)-DTPA-Tc-99m was passive binding. Twenty-four hour necropsy data in the hepatocellular carcinoma tumor model showed significantly higher (p<0.001) tumor localization for poly(HPMA)-porphyrin-DTPA-Tc-99m (5.18 +/- 0.50% ID/g [percentage injected dose per gram tissue]) compared with poly(HPMA)-DTPA-Tc-99m (2.69 +/- 0.15% ID/g) and DTPA-Tc-99m (0.83 +/- 0.03% ID/g). Moreover, higher T/B for poly(HPMA)-porphyrin-DTPA-Tc-99m indicated reduced extravasation of the targeted polymeric conjugates in normal tissues. Thus, the poly(HPMA)-porphyrin-DTPA-Tc-99m is a potential macromolecular tumor targeting molecular agent.
机译:卟啉通常通过低密度脂蛋白的受体介导的内吞作用而被肿瘤组织优先吸收和保留。为了研究主动和被动靶向策略的相对重要性,特异性靶向卟啉HPMA [HPMA:N-(2-羟丙基)甲基丙烯酰胺]共聚物示踪剂聚(HPMA)-卟啉的合成,表征,体外摄取和体内生物分布-DTPA-Tc-99m(DTPA:二亚乙基三胺五乙酸),非特异性靶向HPMA共聚物示踪剂聚(HPMA)-DTPA-Tc-99m和非靶向示踪剂DTPA-Tc-99m。结果表明,聚(HPMA)-卟啉-DTPA-Tc-99m复合物的细胞积累是时间依赖性的。聚(HPMA)-卟啉-DTPA-Tc-99m的摄取显着高于聚(HPMA)-DTPA-Tc-99m的摄取,表明聚(HPMA)-卟啉-DTPA-Tc-99m的摄取为主动绑定。聚(HPMA)-DTPA-Tc-99m的吸收显着高于DTPA-Tc-99m,这表明聚(HPMA)-DTPA-Tc-99m的吸收是被动结合。肝细胞癌肿瘤模型中的24小时尸检数据显示,聚(HPMA)-卟啉-DTPA-Tc-99m的肿瘤定位显着更高(p <0.001)(5.18 +/- 0.50%ID / g [克组织)与聚(HPMA)-DTPA-Tc-99m(2.69 +/- 0.15%ID / g)和DTPA-Tc-99m(0.83 +/- 0.03%ID / g)进行比较。此外,聚(HPMA)-卟啉-DTPA-Tc-99m的更高的T / B表明在正常组织中靶向聚合缀合物的外渗减少。因此,聚(HPMA)-卟啉-DTPA-Tc-99m是潜在的大分子肿瘤靶向分子试剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号